These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16911462)

  • 21. HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.
    Niro GA; Smedile A; Fontana R; Olivero A; Ciancio A; Valvano MR; Pittaluga F; Coppola N; Wedemeyer H; Zachou K; Marrone A; Fasano M; Lotti G; Andreone P; Iacobellis A; Andriulli A; Rizzetto M
    Aliment Pharmacol Ther; 2016 Sep; 44(6):620-8. PubMed ID: 27443972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.
    Gunsar F; Akarca US; Ersoz G; Kobak AC; Karasu Z; Yuce G; Ilter T; Batur Y
    Antivir Ther; 2005; 10(6):721-6. PubMed ID: 16218171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Famciclovir treatment of chronic delta hepatitis.
    Yurdaydin C; Bozkaya H; Gürel S; Tillmann HL; Aslan N; Okçu-Heper A; Erden E; Yalçin K; Iliman N; Uzunalimoglu O; Manns MP; Bozdayi AM
    J Hepatol; 2002 Aug; 37(2):266-71. PubMed ID: 12127433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection.
    Aziz S; Rajper J; Noor-ul-Ain W; Mehnaz A; Masroor M; Chang MH
    J Coll Physicians Surg Pak; 2011 Dec; 21(12):735-40. PubMed ID: 22166693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials.
    Lamers MH; Kirgiz ÖÖ; Heidrich B; Wedemeyer H; Drenth JP
    Antivir Ther; 2012; 17(6):1029-37. PubMed ID: 22892440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months.
    Ormeci N; Bölükbaş F; Erden E; Coban S; Ekiz F; Erdem H; Palabıyıkoğlu M; Beyler AR; Balık I; Bölükbaş C; Nazlıgül Y; Köklü S
    Hepatogastroenterology; 2011; 58(110-111):1648-53. PubMed ID: 22086695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcome in patients of hepatitis B with hepatitis D: experience of 4 years at a tertiary care centre in Pakistan.
    Zuberi BF; Quraishy MS; Afsar S; Akhtar N; Kumar A; Dodani SK
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):320-2. PubMed ID: 17623577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir.
    Borzacov LM; de Figueiredo Nicolete LD; Souza LF; Dos Santos AO; Vieira DS; Salcedo JM
    Int J Infect Dis; 2016 May; 46():82-8. PubMed ID: 27005283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis.
    Kabaçam G; Dalekos GN; Çakaloğlu Y; Zachou K; Bock T; Erhardt A; Zeuzem S; Tabak F; Yalçin K; Bozdayi AM; Dienes HP; Bozkaya H; Manns M; Wedemeyer H; Yurdaydin C
    Turk J Gastroenterol; 2012; 23(5):560-8. PubMed ID: 23161302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
    Zachou K; Yurdaydin C; Drebber U; Dalekos GN; Erhardt A; Cakaloglu Y; Degertekin H; Gurel S; Zeuzem S; Bozkaya H; Schlaphoff V; Dienes HP; Bock TC; Manns MP; Wedemeyer H;
    Liver Int; 2010 Mar; 30(3):430-7. PubMed ID: 19840253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection.
    Jara P; Hierro L; de la Vega A; Díaz C; Camarena C; Frauca E; Miños-Bartolo G; Díez-Dorado R; de Guevara CL; Larrauri J; Rueda M
    Pediatr Infect Dis J; 2008 Feb; 27(2):142-8. PubMed ID: 18174875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response.
    Samiullah S; Bikharam D; Nasreen
    World J Gastroenterol; 2012 Oct; 18(40):5793-8. PubMed ID: 23155322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.
    Flink HJ; Hansen BE; Heathcote EJ; Feinman SV; Simsek H; Karayalcin S; Mach T; Leemans WF; de Man RA; Verhey E; Schalm SW; Janssen HL;
    Am J Gastroenterol; 2006 Nov; 101(11):2523-9. PubMed ID: 17029610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers.
    d'Arondel C; Munteanu M; Moussalli J; Thibault V; Naveau S; Simon A; Messous D; Morra R; Blot C; Poynard T
    J Viral Hepat; 2006 Mar; 13(3):182-9. PubMed ID: 16475994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial.
    Canbakan B; Senturk H; Tabak F; Akdogan M; Tahan V; Mert A; Sut N; Ozaras R; Midilli K; Ozbay G
    J Gastroenterol Hepatol; 2006 Apr; 21(4):657-63. PubMed ID: 16677149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
    ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
    Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
    Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
    Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
    Farci P; Roskams T; Chessa L; Peddis G; Mazzoleni AP; Scioscia R; Serra G; Lai ME; Loy M; Caruso L; Desmet V; Purcell RH; Balestrieri A
    Gastroenterology; 2004 Jun; 126(7):1740-9. PubMed ID: 15188169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.